The Advisor Selection Decision: Selecting the right investment banking advisor for your practice sale is one of the most consequential decisions in the entire transaction process. The right advisor will help increase the practice’s value before going to market, design and manage a competitive sale process, identify and reach all relevant buyers, position your practice compellingly in a Confidential Information Memorandum (CIM), drive competitive tension that maximizes price, negotiate deal terms that protect your interests, and guide you through a complex transaction from engagement letter through closing. The wrong advisor will cost you time, money, and potentially the transaction itself.
Healthcare Specialization Is Non-Negotiable
Physician practice M&A is a specialized discipline with its own regulatory landscape (Stark Law, Anti-Kickback, state corporate practice of medicine laws), its own valuation methodology (normalized EBITDA, fair market value compensation, quality-of-earnings adjustments), and its own buyer universe (PE sponsors with healthcare-specific theses, hospital systems, health plans). A generalist M&A advisor who lacks deep healthcare transactional experience will struggle to navigate these complexities effectively. Meaningful healthcare deal experience, ideally including specific women’s health or OB/GYN transactions, is a minimum qualification threshold, not a differentiating attribute.
Track Record and Buyer Relationships
The quality of an advisor’s buyer relationships is a direct determinant of the competitive tension they can create in your sales process. A firm with established relationships across the full universe of relevant women’s health PE platforms, healthcare-focused PE funds, hospital systems, and strategic consolidators can generate more competitive offers than a firm with limited buyer reach. Ask prospective advisors for specific references from recently closed physician practice transactions and follow up directly with those references to assess the advisor’s process quality, responsiveness, and effectiveness under pressure.
Alignment of Incentives
Investment banking fee structures should align the advisor’s incentives with the seller’s objectives. Most healthcare M&A advisors charge a success fee based on the total transaction value, a structure that motivates advisors to maximize price. Be cautious of advisors who propose flat retainer arrangements without meaningful success fee components, or who have financial relationships with buyers that could create conflicts of interest. The relationship between your investment banker and the buyers they recommend should be transparent, disclosed, and free of material conflicts.
The Value of a Dedicated Advocate
Perhaps the most important quality to assess in a prospective investment banking advisor is their commitment to serving as a genuine advocate throughout the process. Healthcare transactions are inherently stressful, involve significant information asymmetry, and require sustained attention and expertise across financial, legal, operational, and interpersonal dimensions simultaneously. An advisor who has managed multiple physician practice transactions through successful closings, has seen the full range of challenges that arise in complex deals, and knows how to navigate them is invaluable. The most important question to ask a prospective advisor is simple: who specifically on your team will be working on my transaction, and what is their relevant experience?